Itch in ethnic populations

Acta Dermato-Venereologica

Volumn 90, Issue 3, 2010, Pages 227-234

  Tey, Hong Liang ^a   Yosipovitch, Gil ^b  

^a NATIONAL SKIN CENTRE   (Singapore)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Asian; Black; Caucasian; Hispanics; Pruritus; Race

Indexed keywords

CHLOROQUINE; INTERLEUKIN 31;

AMYLOIDOSIS; ATOPIC DERMATITIS; BILIARY CIRRHOSIS; DIABETES MELLITUS; EPIDERMIS; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KELOID; LICHEN PLANUS; LICHEN PLANUS PIGMENTOSUS; MYCOSIS FUNGOIDES; PREGNANCY; PRIMARY CUTANEOUS AMYLOIDOSIS; PRIORITY JOURNAL; PRURIGO PIGMENTOSA; PRURITIC PAPULAR ERUPTION; PRURITUS; REVIEW; SKIN DISEASE; SKIN NERVE;

ANTIPRURITICS; CHRONIC DISEASE; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS DISPARITIES; HUMANS; PREVALENCE; PRURITUS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77953468606     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0867     Document Type: Review

References (89)

1. Gunathilake R, Schurer NY, Shoo BA, Celli A, Hachem JP, Crumrine D, et al. pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol 2009; 129: 1719-1729.
2. Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010; 49: 1-11.
3. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006; 7: 535-547.
4. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 2009; 9: 437-446.
5. Rawlings AV. Ethnic skin types: are there differences in skin structure and function? Int J Cosmet Sci 2006; 28: 79-93.
6. Maddison B, Foy V, Stocks J, Singleton S, McGlone F. Japanese cheek skin has greater ASIC and heightened sensory thresholds compared to hairline skin. J Invest Dermatol 2009; 129: S77-S77, meeting abstract: 457.
7. Wesley NO, Maibach HI. Racial (ethnic) differences in skin properties: the objective data. Am J Clin Dermatol 2003; 4: 843-860.
8. Wang H, Papoiu AD, Coghill RC, Patel T, Wang N, Yosipovitch G. Ethnic differences in pain, itch and thermal detection in response to topical capsaicin: African Americans display a notably limited hyperalgesia and neurogenic inflammation. Br J Dermatol 2009 Dec 19. [Epub ahead of print].
9. Tan EC, Lim EC, Teo YY, Lim Y, Law HY, Sia AT. Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 2009 23; 5: 32.
10. Wu WD, Wang Y, Fang YM, Zhou HY. Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery. Mol Diagn Ther 2009; 13: 331-337.
11. Dalgard F, Holm JO, Svensson A, Kumar B, Sundby J. Self reported skin morbidity and ethnicity: a population based study in a Western community. BMC Dermatol 2007; 7: 4.
12. Marmot MG, Adelstein AM, Bulusu L. Lessons from the study of immigrant mortality. Lancet 1984; 1: 1455-1457.
13. Nazroo JY. South Asian people and heart disease: an assessment of the importance of socioeconomic position. Ethn Dis 2001; 11: 401-411.
14. Matterne U, Strassner T, Apfelbacher CJ, Diepgen TL, Weisshaar E. Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies. Acta Derm Venereol 2009; 89: 250-256.
15. Sommer F, Hensen P, Böckenholt B, Metze D, Luger TA, Ständer S. Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol 2007; 87: 510-516.
16. Weisshaar E, Apfelbacher C, Jager G, Zimmermann E, Bruckner T, Diepgen TL, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 2006; 155: 957-964.
17. Schreml S, Schroeder J, Eder F, Szeimies RM, Landthaler M, Babilas P. Hereditary and non-hereditary cutaneous amyloidoses. Pathologe 2009; 30: 197-204.
18. Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, et al. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 2008; 82: 73-80.
19. Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol 2003; 48: S143-148.
20. McDonald RR, Georgouras KE. Skin disorders in Indo-Chinese immigrants. Med J Aust 1992; 156: 847-853.
21. Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18: 1-16.
22. Tay CH, Dacosta JL. Lichen amyloidosus - clinical study of 40 cases. Br J Dermatol 1970; 82: 129-137.
23. Al Ratrout JT, Satti MB. Primary localised cutaneous amylodosis: a clinical pathologic study from Saudi Arabia. Int J Dermatol 1997; 36: 428-434.
24. Salim T, Shenoi SD, Balachandran C, Mehta VR. Lichen amyloidosus: a study of clinical, histopathologic and immunofluorescence findings in 30 cases. Indian J Dermatol Venereol Leprol 2005; 71: 166-169. (Pubitemid 40898199)
25. Maddison B, Namazi MR, Samuel LS, Sanchez J, Pichardo R, Stocks J, et al. Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosus. Br J Dermatol 2008; 159: 403-406.
26. Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol 2009; 161: 1217-1224.
27. Lin MW, Lee DD, Liu TT, Lin YF, Chen SY, Huang CC, et al. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis. Eur J Hum Genet 2010; 18: 26-32.
28. Nagashima M, Ohshiro A, Shimizu N. A peculiar pruriginous dermatosis with gross reticular pigmentation. Jpn J Dermatol 1971; 81: 78-91.
29. Nagashima M. Prurigo pigmentosa - clinical observations of our 14 cases. J Dermatol 1978; 5: 61-67. (Pubitemid 8353848)
30. Boer A, Misago N, Wolter M, Kiryu H, Wang XD, Ackerman AB. Prurigo pigmentosa: a distinctive inflammatory disease of the skin. Am J Dermatopathol 2003; 25: 117-129. (Pubitemid 36350457)
31. De Francesco V, Quinkenstein E, Mariuzzi L, Frattasio A, Pillon B, Patrone P. Bullous prurigo pigmentosa. Eur J Dermatol 2006; 16: 184-186.
32. Kim SK, Kang HY, Lee ES. Bullous prurigo pigmentosa. Int J Dermatol 2007; 46: 888-890.
33. Boer A, Asgari M. Prurigo pigmentosa: an underdiagnosed disease? Indian J Dermatol Venereol Leprol 2006; 72: 405-409.
34. Baykal C, Buyukbabani N, Akinturk S, Saglik E. Prurigo pigmentosa: not an uncommon disease in the Turkish population. Int J Dermatol 2006; 45: 1164-1168.
35. Cox NH. Prurigo pigmentosa. Br J Dermatol 1987; 117: 121-124.
36. Liu MT, Wong CK. Prurigo pigmentosa. Dermatology 1994; 188: 219-221.
37. Kim MH, Choi YW, Choi HY, Myung KB. Prurigo pigmentosa from contact allergy to chrome in detergent. Contact Dermatitis 2001; 44: 289-292.
38. Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol 2002; 147: 920-925.
39. Kelly AP. Update on the management of keloids. Semin Cutan Med Surg 2009; 28: 71-76.
40. Lee SS, Yosipovitch G, Chan YH, Goh CL. Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol 2004; 51: 1002-1006.
41. Tey HL. A practical classification of childhood hypopigmentation disorders. Acta Derm Venereol 2010; 90: 6-11.
42. Ardigó M, Borroni G, Muscardin L, Kerl H, Cerroni L. Hypopigmented mycosis fungoides in Caucasian patients: a clinicopathologic study of 7 cases. J Am Acad Dermatol 2003; 49: 264-270.
43. Stone ML, Styles AR, Cockerell CJ, Pandya AG. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 2001; 67: 133-138. (Pubitemid 33756245)
44. Kanwar AJ, Dogra S, Handa S, Parsad D, Radotra BD. A study of 124 Indian patients with lichen planus pigmentosus. Clin Exp Dermatol 2003; 28: 481-485.
45. Bhutani L, Bedi T, Pandhi R. Lichen planus pigmentosus. Dermatologica 1974; 149: 43-50.
46. Al-Mutairi N, El-Khalawany M. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol 2009 Oct 15. [Epub ahead of print].
47. Kashima A, Tajiri A, Yamashita A, Asada Y, Setoyama M. Two Japanese cases of lichen planus pigmentosus-inversus. Int J Dermatol 2007; 46: 740-742.
48. Hong S, Shin JH, Kang HY. Two cases of lichen planus pigmentosus presenting with a linear pattern. J Korean Med Sci 2004; 19: 152-154. (Pubitemid 38296294)
49. Pock L, Jelinkova L, Drlik L, Abrhámová S, Vojtechovská S, Sezemská D, et al. Lichen planus pigmentosus-inversus. J Eur Acad Dermatol Venereol 2001; 15: 452-454.
50. Vega ME, Waxtein L, Arenas R, Hojyo T, Dominguez-Soto L. Ashy dermatosis and lichen planus pigmentosus: a clinicopathologic study of 31 cases. Int J Dermatol 1992; 31: 90-94.
51. Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol 2009; 89: 339-350.
52. Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495-3505.
53. Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003; 17: 857-870.
54. Talwalkar JA, Souto E, Jorgensen RA, Lindor KD. Natural history of pruritus in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2003; 1: 297-302.
55. Wong RK, Lim SG, Wee A, Chan YH, Aung MO, Wai CT. Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population. J Gastroenterol Hepatol 2008; 23: 599-605.
56. Peters MG, Di Bisceglie AM, Kowdley KV, Flye NL, Luketic VA, Munoz SJ, et al. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology 2007; 46: 769-775.
57. Gelfand JM, Rudikoff D. Evaluation and treatment of itching in HIV-infected patients. Mt Sinai J Med 2001; 68: 298-308. (Pubitemid 32717825)
58. Eisman S. Pruritic papular eruption in HIV. Dermatol Clin 2006; 24: 449-457.
59. Fisher BK, Warner LC. Cutaneous manifestations of the acquired immunodeficiency syndrome. Int J Dermatol 1987; 26: 262-264.
60. Colebunders R, Mann JM, Francis H, Bila K, Izaley L, Kakonde N, et al. Generalized papular pruritic eruptions in African patients with HIV infection. AIDS 1987; 1: 117-121.
61. Cardoso F, Ramos H, Lobo M. Epidemiologic profile of HIV - positive patients with dermatoses in Natal/RN/Brazil. Anais Bras. Dermatol 2003; 78: 35-47.
62. Liautaud B, Pape JW, DeHovitz JA, Thomas F, LaRoche AC, Verdier RI, et al. Pruritic skin lesions. A common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 1989; 125: 629-632.
63. Boonchai WB, Laohasrisakul R, Manonukul J, Kulthanan K. Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression. Int J Dermatol 1999; 38: 348-350.
64. Yosipovitch G, Dawn AG, Greaves MW. Pathophysiology and clinical aspects of pruritus. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine, 7th edn. New York: McGraw-Hill, 2008: p. 908.
65. Neilly JB, Martin A, Simpson N, MacCuish AC. Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control. Diabetes Care 1986; 9: 273-275. (Pubitemid 16060912)
66. Yamaoka H, Sasaki H, Yamasaki H, Ogawa K, Ohta T, Furuta H, et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care 2010; 33: 150-155.
67. Mahajan S, Koranne RV, Sharma SK. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol 2003; 69: 105-108.
68. Al-Mutairi N, Zaki A, Sharma AK, Al-Sheltawi M. Cutaneous manifestations of diabetes mellitus. Study from Farwaniya hospital, Kuwait. Med Princ Pract 2006; 15: 427-430.
69. Murdoch ME, Asuzu MC, Hagan M, Makunde WH, Ngoumou P, Ogbuagu KF, et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol 2002; 96: 283-296.
70. Won KY, Kruszon-Moran D, Schantz PM, Jones JL. National seroprevalence and risk factors for Zoonotic Toxocara spp. infection. Am J Trop Med Hyg 2008; 79: 552-557.
71. Ekpechi OL, Okoro AN. A pattern of pruritus due to chloroquine. Arch Dermatol 1964; 89: 631-632.
72. Ajayi AA, Oluokun A, Sofowora O, Akinleye A, Ajayi AT. Epidemiology of antimalarial-induced pruritus in Africans. Eur J Clin Pharmacol 1989; 37: 539-540.
73. Olayemi O, Fehintola FA, Osungbade A, Aimakhu CO, Udoh ES, Adeniji AR. Pattern of chloroquine-induced pruritus in antenatal patients at the University College Hospital, Ibadan. J Obstet Gynaecol 2003; 23: 490-495.
74. Gama H, Ismael A, Sitoi F, Matola A, Barros H, Lunet N. Factors associated with chloroquine induced pruritus during malaria treatment in Mozambican University students. Gac Sanit 2009; 23: 306-310.
75. Spencer HC, Kaseje DC, Brandling-Bennett AD, Oloo AJ, Watkins WM. Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya. Ann Trop Med Parasitol 1987; 81: 124-127.
76. Jimenez-Alonso J, Tercedor J, Jaimez L, Garcia-Lora E. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus. Arthritis Rheum 1998; 41: 744-745.
77. Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 2009; 139: 1353-1365.
78. Bandell M, Patapoutian A. Itching for insight. Cell 2009; 139: 1224-1226.
79. Karen JK, Pomeranz MK. Skin changes and diseases in pregnancy. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine, 7th edn. New York: McGraw-Hill, 2008: p. 958.
80. Beuers U, Pusl T. Intrahepatic cholestasis of pregnancy - a heterogeneous group of pregnancy-related disorders? Hepatology 2006; 43: 647-649.
81. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000; 33: 1012-1021.
82. Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 1978; 88: 487-493. (Pubitemid 8330294)
83. Reyes H, Taboada G, Ribalta J. Prevalence of intrahepatic cholestasis of pregnancy in La Paz, Bolivia. J Chronic Dis 1979; 32: 499-504.
84. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997; 12: 211-216. (Pubitemid 27157993)
85. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology 2008; 47: 376-379.
86. Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26: 358-364.
87. Sheiner E, Ohel I, Levy A, Katz M. Pregnancy outcome in women with pruritus gravidarum. J Reprod Med 2006; 51: 394-398. (Pubitemid 43765081)
88. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009; 15: 2049-2066.
89. Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 1999; 4: 35-37.